Matches in Nanopublications for { ?s ?p "[Prolonged OC use was more strongly associated with p53+ breast cancer [OR 3.1 (95% CI: 1.2-8.1) than p53- breast cancer (OR 1.3 (95% CI: 0.6-3.2)] among younger women only.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP487578.RAZwJ--WfsS5WTy34m6Gty0SVEMzpaj4xJVYmGr3rAPnQ130_assertion description "[Prolonged OC use was more strongly associated with p53+ breast cancer [OR 3.1 (95% CI: 1.2-8.1) than p53- breast cancer (OR 1.3 (95% CI: 0.6-3.2)] among younger women only.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP487578.RAZwJ--WfsS5WTy34m6Gty0SVEMzpaj4xJVYmGr3rAPnQ130_provenance.
- NP968984.RAUZosSBPAN-8KkTlhnGZoHFxzwSSXIzEvrPZT1mph1ds130_assertion description "[Prolonged OC use was more strongly associated with p53+ breast cancer [OR 3.1 (95% CI: 1.2-8.1) than p53- breast cancer (OR 1.3 (95% CI: 0.6-3.2)] among younger women only.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP968984.RAUZosSBPAN-8KkTlhnGZoHFxzwSSXIzEvrPZT1mph1ds130_provenance.
- NP609828.RAJY1Fe4ke4lat3iHi4723R5iuXacqe7Rl_Wc54RxJKf4130_assertion description "[Prolonged OC use was more strongly associated with p53+ breast cancer [OR 3.1 (95% CI: 1.2-8.1) than p53- breast cancer (OR 1.3 (95% CI: 0.6-3.2)] among younger women only.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP609828.RAJY1Fe4ke4lat3iHi4723R5iuXacqe7Rl_Wc54RxJKf4130_provenance.
- NP968960.RAk4WtIlui9ZfhNXQo1u4cFdvqv0lMFsQpVUwjAzwBL90130_assertion description "[Prolonged OC use was more strongly associated with p53+ breast cancer [OR 3.1 (95% CI: 1.2-8.1) than p53- breast cancer (OR 1.3 (95% CI: 0.6-3.2)] among younger women only.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP968960.RAk4WtIlui9ZfhNXQo1u4cFdvqv0lMFsQpVUwjAzwBL90130_provenance.